Graduate Program in Cellular and Molecular Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY.
Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, Ontario, Canada.
J Gen Physiol. 2021 Aug 2;153(8). doi: 10.1085/jgp.202012855. Epub 2021 Jun 1.
Desensitization is a common feature of ligand-gated ion channels, although the molecular cause varies widely between channel types. Mutations that greatly reduce or nearly abolish desensitization have been described for many ligand-gated ion channels, including glutamate, GABA, glycine, and nicotinic receptors, but not for acid-sensing ion channels (ASICs) until recently. Mutating Gln276 to a glycine (Q276G) in human ASIC1a was reported to mostly abolish desensitization at both the macroscopic and the single channel levels, potentially providing a valuable tool for subsequent studies. However, we find that in both human and chicken ASIC1, the effect of Q276G is modest. In chicken ASIC1, the equivalent Q277G slightly reduces desensitization when using pH 6.5 as a stimulus but desensitizes, essentially like wild-type, when using more acidic pH values. In addition, steady-state desensitization is intact, albeit right-shifted, and recovery from desensitization is accelerated. Molecular dynamics simulations indicate that the Gln277 side chain participates in a hydrogen bond network that might stabilize the desensitized conformation. Consistent with this, destabilizing this network with the Q277N or Q277L mutations largely mimics the Q277G phenotype. In human ASIC1a, the Q276G mutation also reduces desensitization, but not to the extent reported previously. Interestingly, the kinetic consequences of Q276G depend on the human variant used. In the common G212 variant, Q276G slows desensitization, while in the rare D212 variant desensitization accelerates. Our data reveal that while the Q/G mutation does not abolish or substantially impair desensitization as previously reported, it does point to unexpected differences between chicken and human ASICs and the need for careful scrutiny before using this mutation in future studies.
脱敏作用是配体门控离子通道的一个共同特征,尽管在通道类型之间,其分子原因差异很大。包括谷氨酸、GABA、甘氨酸和烟碱型乙酰胆碱受体在内的许多配体门控离子通道都已被描述存在极大降低或几乎消除脱敏作用的突变,但直到最近才在酸敏离子通道(ASICs)中发现这种突变。有报道称,在人类 ASIC1a 中,将 Gln276 突变为甘氨酸(Q276G),在宏观和单通道水平上基本消除了脱敏作用,这可能为随后的研究提供了有价值的工具。然而,我们发现,在人类和鸡的 ASIC1 中,Q276G 的作用并不显著。在鸡的 ASIC1 中,当使用 pH 6.5 作为刺激时,等效的 Q277G 会稍微降低脱敏作用,但当使用更酸性的 pH 值时,它会像野生型一样脱敏。此外,稳态脱敏作用完好无损,尽管右移,从脱敏状态恢复的速度加快。分子动力学模拟表明,Gln277 侧链参与氢键网络,可能稳定脱敏构象。这与 Q277N 或 Q277L 突变破坏这个网络的情况基本一致,这两种突变在很大程度上模拟了 Q277G 的表型。在人类 ASIC1a 中,Q276G 突变也降低了脱敏作用,但程度不如之前报道的那么大。有趣的是,Q276G 的动力学后果取决于所使用的人类变体。在常见的 G212 变体中,Q276G 会使脱敏作用减慢,而在罕见的 D212 变体中,脱敏作用会加速。我们的数据表明,尽管 Q/G 突变没有像之前报道的那样完全消除或显著损害脱敏作用,但它确实指出了鸡和人类 ASIC 之间的意外差异,在未来的研究中使用这种突变之前,需要仔细审查。